Press Releases
February 22, 2006
Xanodyne Pharmaceuticals to Present at Future Leaders in the Biotech Industry 2006 Conference
For Immediate Release
Newport, KY – February [ ], 2006 – Xanodyne Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women's health and pain management, today announced that Mr. William Nuerge, Chief Executive of Xanodyne Pharmaceuticals, Inc., will be presenting at the Future Leaders in the Biotech Industry 2006 Conference, hosted by BioCentury Publications, Inc., in New York on March 30, 2006.
Xanodyne Pharmaceuticals, Inc. is a privately owned, fully integrated, branded specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women's health and pain management. The company, located in the greater Cincinnati area, has a nationwide sales force and currently markets numerous pharmaceutical products. More information regarding Xanodyne can be accessed at www.xanodyne.com.